Results
2302
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2302 companies
Helix BioPharma
Market Cap: CA$50.4m
Operates as an immune-oncology company in Canada.
HBP
CA$0.92
7D
-3.2%
1Y
-10.2%
Futura Medical
Market Cap: UK£26.9m
Research, develops, and sells pharmaceutical and healthcare products for sexual health.
FUM
UK£0.088
7D
-0.7%
1Y
-76.8%
Poolbeg Pharma
Market Cap: UK£26.8m
Operates as a biopharmaceutical company, engages in the development and commercialization of medicines for unmet medical needs in the United Kingdom.
POLB
UK£0.038
7D
48.1%
1Y
-70.7%
Renalytix
Market Cap: UK£26.5m
Develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management kidney diseases in the United States.
RENX
UK£0.08
7D
-5.9%
1Y
-57.9%
Retrieve Medical Holdings
Market Cap: US$35.5m
Develops software solutions related to data mining, clinical decision support, natural language processing, and algorithmic testing for analyzing patient’s accumulated medical records and lab results in medical center emergency departments.
RMHI
US$1.50
7D
-40.0%
1Y
-62.5%
Rani Therapeutics Holdings
Market Cap: US$35.5m
Operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.
RANI
US$0.62
7D
-17.1%
1Y
-86.5%
Lantern Pharma
Market Cap: US$35.5m
Focuses on the discovery and development of oncology drug.
LTRN
US$2.90
7D
-16.7%
1Y
-53.1%
AN2 Therapeutics
Market Cap: US$35.3m
A biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics.
ANTX
US$1.18
7D
-0.8%
1Y
-44.3%
Pluri
Market Cap: US$35.1m
A biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries.
PLUR
US$4.55
7D
-6.6%
1Y
-31.1%
Burning Rock Biotech
Market Cap: US$35.0m
Primarily develops and sells cancer therapy selection tests in the People's Republic of China.
BNR
US$3.29
7D
13.1%
1Y
-56.4%
Quantum BioPharma
Market Cap: CA$48.2m
Operates as a biopharmaceutical company.
QNTM
CA$15.90
7D
0.3%
1Y
-48.0%
Propanc Biopharma
Market Cap: US$34.8m
A biopharmaceutical company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia.
PPCB
US$3.15
7D
26.5%
1Y
-95.6%
Envoy Medical
Market Cap: US$34.8m
A hearing health company, focuses on providing medical technologies across the hearing loss spectrum.
COCH
US$1.56
7D
-9.3%
1Y
-40.5%
Microbix Biosystems
Market Cap: CA$47.9m
A life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally.
MBX
CA$0.34
7D
1.5%
1Y
6.2%
Rafael Holdings
Market Cap: US$34.6m
Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel.
RFL
US$1.30
7D
-4.4%
1Y
-17.2%
MedAdvisor
Market Cap: AU$53.7m
Provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom.
MDR
AU$0.086
7D
-2.3%
1Y
-80.2%
Light AI
Market Cap: CA$47.9m
A healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities.
ALGO
CA$0.40
7D
23.4%
1Y
n/a
Proteomics International Laboratories
Market Cap: AU$53.7m
Operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and South East Asia.
PIQ
AU$0.41
7D
3.8%
1Y
-58.2%
Boundless Bio
Market Cap: US$34.5m
A clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA).
BOLD
US$1.30
7D
-21.7%
1Y
-86.5%
Shield Therapeutics
Market Cap: UK£25.5m
A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.
STX
UK£0.025
7D
2.1%
1Y
4.3%
Golden Valley Development
Market Cap: US$34.2m
Through its subsidiaries, manufactures and markets patented products in the health care and home consumer markets sectors.
GVDI
US$0.05
7D
0%
1Y
400.0%
Reliq Health Technologies
Market Cap: CA$47.3m
A healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market.
RHT
CA$0.21
7D
0%
1Y
-57.0%
Defence Therapeutics
Market Cap: CA$47.1m
Develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases.
DTC
CA$0.87
7D
-4.4%
1Y
-24.3%
Ocumetics Technology
Market Cap: CA$46.7m
Engages in research, development, production, and sale of vision enhancement products in Canada.
OTC
CA$0.39
7D
8.3%
1Y
30.0%
LAVA Therapeutics
Market Cap: US$33.7m
Operates as a clinical-stage immuno-oncology company that focuses on developing cancer treatments.
LVTX
US$1.29
7D
-2.3%
1Y
-46.0%
Aligos Therapeutics
Market Cap: US$33.6m
A clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases.
ALGS
US$5.59
7D
-7.8%
1Y
-63.5%
Rockwell Medical
Market Cap: US$33.5m
Develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide.
RMTI
US$0.96
7D
-10.0%
1Y
-46.2%
Compumedics
Market Cap: AU$51.9m
Engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe.
CMP
AU$0.27
7D
-10.0%
1Y
14.9%
FibroGen
Market Cap: US$33.3m
A biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.
FGEN
US$0.32
7D
-6.6%
1Y
-74.9%
Precision Optics Corporation
Market Cap: US$33.2m
Designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States.
POCI
US$4.66
7D
6.6%
1Y
-29.1%
MTL Cannabis
Market Cap: CA$45.6m
Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.
MTLC
CA$0.37
7D
15.6%
1Y
25.4%
Abingdon Health
Market Cap: UK£24.4m
Operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally.
ABDX
UK£0.065
7D
6.6%
1Y
-40.9%
KDA Group
Market Cap: CA$45.3m
Provides technological solutions to general and specialized health sectors in Canada.
KDA
CA$0.24
7D
-5.8%
1Y
-35.5%
Tryptamine Therapeutics
Market Cap: AU$50.4m
A clinical-stage pharmaceutical development company, focuses on developing synthetic psilocybin-related molecules in Australia, Canada, Switzerland, and the United States.
TYP
AU$0.035
7D
-5.4%
1Y
n/a
Theralase Technologies
Market Cap: CA$44.8m
A clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally.
TLT
CA$0.17
7D
-2.8%
1Y
6.1%
Cyclacel Pharmaceuticals
Market Cap: US$32.3m
A clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States.
CYCC
US$1.62
7D
-7.4%
1Y
-95.0%